Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $514.9500 (1.43%) ($514.9500 - $514.9500) on Thu. May. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 72 | Latest Price | $514.9500(1.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 2.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(36%) SPLV(36%) IWD(35%) | Factors Impacting REGN price | REGN will decline at least -0.785% in a week (0% probabilities). VIXM(-20%) TBT(-7%) UUP(-6%) VXX(-5%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $515.96(-0.2%) | 10 Day Moving Average | $510.75(0.82%) | 20 Day Moving Average | $500.27(2.93%) | To recent high | -1.6% | To recent low | 15.3% | Market Cap | $54.599b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |